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Abstract
Most humans harbor both CD177neg and CD177pos neutrophils but 1–10% of people are
CD177null, placing them at risk for formation of anti-neutrophil antibodies that can cause trans-
fusion-related acute lung injury and neonatal alloimmune neutropenia. By deep sequencing
theCD177 locus, we cataloguedCD177 single nucleotide variants and identified a novel stop
codon in CD177null individuals arising from a single base substitution in exon 7. This is not a
mutation inCD177 itself, rather the CD177null phenotype arises when exon 7 ofCD177 is sup-
plied entirely by the CD177 pseudogene (CD177P1), which appears to have resulted from
allelic gene conversion. In CD177 expressing individuals theCD177 locus contains both
CD177P1 andCD177 sequences. The proportion of CD177hi neutrophils in the blood is a her-
itable trait. Abundance of CD177hi neutrophils correlates with homozygosity forCD177 refer-
ence allele, while heterozygosity for ectopicCD177P1 gene conversion correlates with
increased CD177neg neutrophils, in which bothCD177P1 partially incorporated allele and
paired intactCD177 allele are transcribed. Human neutrophil heterogeneity for CD177
expression arises by ectopic allelic conversion. Resolution of the genetic basis of CD177null
phenotype identifies a method for screening for individuals at risk of CD177 isoimmunisation.
Author Summary
Expression of the neutrophil-specific antigen CD177 varies across the population. 1–10%
of humans are CD177null. CD177pos neonates born to CD177null mothers are susceptible
to alloimmune neutropenia. Interestingly, CD177pos and CD177neg populations of
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neutrophils often exist together within individuals. The reasons for heterogeneous CD177
expression are not well understood. We deep sequenced the CD177 locus in individuals
with different levels of CD177 expression, catalogued CD177 single nucleotide variants,
and identified a premature stop codon that causes lack of CD177 expression. Comparison
of messenger RNA from neutrophils with genomic CD177 DNA identified significant
sequence similarity with CD177P1 pseudogene, which probably explains existing misan-
notation in public databases, but also explains susceptibility to cross-over errors. Indeed,
we report that the stop codon responsible for the CD177null phenotype arises when exon 7
of CD177 gene is supplied entirely by CD177P1 by gene conversion. We also show that the
proportion of CD177hi neutrophil numbers within individuals is a heritable trait, deter-
mined by the proportion of intact CD177 and converted CD177 alleles. Furthermore,
within individuals, CD177 gene is differentially transcribed in CD177neg and CD177hi neu-
trophils. Our work resolves the genetic basis of CD177 phenotype and identifies a method
for screening individuals at risk of CD177 isoimmunisation.
Introduction
CD177 (also known as neutrophil specific antigen B1 [NB1], human neutrophil antigen 2a
[HNA-2a], and polycythemia rubra vera 1 [PRV1]) is a 56–64 kDa protein belonging to the
Ly-6 family [1, 2], and is expressed exclusively on neutrophils by glycosylphosphatidylinositol
(GPI)-linkage [3, 4]. CD177 expression is heterogeneous within the human population. 1–10%
of people are CD177null, while the remainder harbor neutrophils that are bi- or tri-modal for
CD177 expression [4–6].
Heterogeneity for neutrophil surface antigen expression within the population results in
susceptibility to alloantibody formation due to loss of acquired immunological tolerance.
Transplacental passage or transfusion of neutrophil antibodies have been implicated in severe
neonatal alloimmune neutropenia (NAN) [7] and transfusion related acute lung injury
(TRALI) [8, 9]. Polymorphic human neutrophil antigens (HNA) include CD16 or FcγRIIIb
(HNA-1a, -1b, -1c and -1d, encoded by FCGR3B) [10], CD177 (HNA-2a, encoded by CD177)
[11, 12], choline transporter-like protein 2 (HNA-3a) [13–15], CD11b (HNA-4a) and CD11a
(HNA-5a) [16–19]. In some cases, the genetic polymorphisms that account for alloantigenicity
have been resolved. For example, three separate alleles of FCGR3B (designated HNA-1a, -1b,
and -1c) appear to account for CD16 alloantigenicity, and the different epitopes of each defined
isoform are specified by variations of five amino acid exchanges [10, 20–22]. Similarly, single
amino acid substitutions account for HNA-3a antigenicity [13, 14, 23]. Absence of HNA-1a,
-1b, -1c, -1d, HNA-3a, HNA-4a and HNA-5a has been associated with formation of maternal
alloantibodies [24, 25]. CD177 deficiency has also been shown to result in development of
maternal alloantibodies that cause neonatal alloimmune neutropenia [11]. In addition, CD177
is pertinent to systemic vasculitis, since one of the principal autoantigens, proteinase 3, is a con-
stituent of primary granules, but is exposed on the neutrophil surface in association with
CD177 [26, 27]. Complete elucidation of the genetic basis of neutrophil alloantigenic variation
is an important goal, since testing for neutrophil antibodies is technically challenging and lim-
ited in current clinical practice [28]. By contrast, identification of the genetic basis of antigen
expression, particularly for absence of antigen, permits screening individuals at risk of generat-
ing specific antibodies in these disease settings [29].
Variation in CD177 expression has been the subject of previous investigations (S1 Table).
Analysis of mRNA amplified from neutrophils of two CD177null donors showed two separate
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RNA insertions. In one case, there was an intronic fragment inserted into exon 6, and in the
other an alternative 5’ end splicing donor of exon 4. Both were postulated to cause loss of
CD177 expression by introducing an in-frame premature stop codon [30, 31] (S1 Fig). Further
investigation revealed an association between certain CD177 single nucleotide variations
(SNVs) and different CD177 phenotypes, although the mechanism to account for these effects
was not elucidated, and the association was insufficient to permit diagnostic testing [32, 33].
More recently, a SNV of cDNA829A>T mutation that introduces a stop codon was identified
in CD177 as a cause for loss of CD177 expression [34].
We set out to determine the genetic basis of inter- and intra-individual CD177 phenotypes,
by deep sequencing neutrophil-derived genomic DNA across the CD177 locus. Taking this
approach, we confirmed the stop codon identified by Li et al in CD177null individuals, but dis-
covered that variation arises when exon 7 of CD177 gene is supplied entirely by allelic conver-
sion with the CD177 pseudogene (CD177P1), which comprises sequences homolog of CD177
exons 4–9 on the minus strand. This variant is present within the germline rather than somati-
cally acquired within neutrophils. Individuals who are homozygous for CD177 have higher
CD177 expression, whereas individuals with ectopic CD177P1 exon 7 conversion have larger
proportions of CD177neg neutrophils in the blood. We demonstrated that CD177 is a heritable
trait determined by the ratio of CD177/CD177P1 alleles, and uncovered distinctive CD177
transcription in CD177neg and CD177hi neutrophils within the same individual. These findings
resolve the basis of interindividual (CD177null versus CD177 expressing) and intra-individual
(CD177neg versus CD177hi subsets) CD177 expression, and identify a method for screening for
individuals at risk of CD177 isoimmunisation.
Results
CD177 heterogeneity
Our discovery cohort comprised 40 patients with systemic vasculitis (cohort 1), and emerged
as part of investigation of expression of vasculitis-associated autoantigens (proteinase 3 (PR3),
myeloperoxidase, and the associated alloantigen CD177). Our study population was made up
of individuals of European, Asian and Australian self-reported ethnicity (S2A Fig). Consistent
with previous reports [33, 35], we identified three neutrophil populations according to CD177
expression: negative (neg), intermediate (int) and high (hi). The majority of individuals were
bi-modal for CD177 (CD177hi and CD177neg) (Fig 1A), while some individuals harbor a sub-
stantial proportion (>20%) of neutrophils expressing CD177 at intermediate levels (Fig 1B). In
a larger cohort (n = 535) of healthy donors (cohort 2), 65.4% of the subjects’ neutrophils were
predominantly CD177hi (Fig 1C), while in 24.7% of the cohort, the distribution of CD177hi
and CD177neg were similar (CD177hi/neg). 2.6% (n = 14) were found to be CD177null. A similar
prevalence of CD177 phenotypes were observed in both cohorts (S2B Fig). We found that
CD177 phenotypes are stable within individuals over six months (S2C, S2D and S2E Fig). Flow
cytometric analysis using two different CD177 monoclonal antibodies (MEM-166 and
REA258) yielded similar results, indicating absence of CD177 expression rather than modifica-
tion of a CD177 epitope in CD177null (Fig 1D).
Two exons with enriched SNV density and a novel stop codon variation
in CD177 gene
We deep sequenced CD177 in cohort 1. To ensure that we did not miss somatic mutations we
isolated genomic DNA using a custom capture array specifically from neutrophils purified
from each subject. Loci containing all nine CD177 exons were isolated and deep sequenced
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(>9,000x) (Fig 2A). We identified 41 SNVs, including 17 in the coding regions (Fig 2A and 2B
and Table 1). These included common non-synonymous SNVs in exon 5 (rs12981714,
rs12980412 and rs12981771) in 39/40 subjects. We also identified three non-synonymous
SNVs in exon 7 (rs200145410, rs200006364 and rs201266439) and three novel variants located
within five nucleotides of each other in all 40 subjects. One of these novel variants (genomic
location 19:43,361,169, c.787A>T, g.7497A>T in hg38) changes a lysine codon (AAA) to a
stop codon (TAA). This variant was present in 100% of reads from two individuals with
CD177null phenotype.
We designed a high throughput assay using two-tailed allele specific primers for universal
energy-transfer amplification (Amplifluor PCR), which identifies reference g.7497A and vari-
ant T alleles [36]. This correctly identified all genotypes defined by deep sequencing, and con-
firmed that the variant allele occurs with frequencies of 100, 75 and 50% in our test cohort
(S3D and S3E Fig). Next, we genotyped the 535 healthy subjects in cohort 2 (S3F Fig) and
found a similar distribution of genotypes as in cohort 1 (S3G Fig). Analysis of population fre-
quencies of CD177 g.7497 genotypes was similar in individuals from each ethnic group (S3H
Fig).
Fig 1. CD177 expression in neutrophils. A. Neutrophils of 5 subjects were gated on CD66b+ cells and analysed for surface expression of CD177.
Three neutrophil subsets defined by CD177 expression were shown: negative (neg) in black, intermediate (int) in orange and high (hi) in pink,
percentages of each subset were indicated as numbers in the same colour. B. Atypical CD177 expression with CD177int subset >20% of neutrophils. C.
A dot plot showing percentages of CD177hi versus CD177neg of total neutrophils in healthy subjects, each dot represents one subject. Three major
phenotypic groups were marked as CD177hi, CD177hi/neg, and CD177null. D. Contour plots showing neutrophils from a CD177null subject (left) and a tri-
model CD177 expressing donor (right), co-stained with two CD177 specific monoclonal antibodies (MEM-166 and REA258).
doi:10.1371/journal.pgen.1006067.g001
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Neutrophil CD177 variations are germline encoded
SNVs identified by deep sequencing were confirmed by Sanger sequencing (Fig 2C). In addi-
tion, we compared sequences obtained from genomic DNA isolated from saliva and neutro-
phils, to determine whether CD177 exon 7 variations were transmitted in the germline or arose
spontaneously by somatic mutation in neutrophils, and whether variant alleles were repre-
sented at different frequencies in individuals with different neutrophil phenotypes. Results
were perfectly concordant with those obtained by deep sequencing, and confirmed all CD177
sequence variants, including the novel stop codon CD177 g.7497T (K263X), in DNA from both
neutrophils and saliva, and consistent with allelic ratios derived from deep sequencing in neu-
trophil-derived DNA (Fig 2A and 2C).
We also examined all variants by in silico prediction algorithms, as our recent analysis on
de novo or low-frequency missense mutations revealed that deleterious effects might be over-
estimated in animal models [37]. Although only the stop gain K263X variation segregates with
Fig 2. Two exons of enriched SNP density and a novel stop codon variation inCD177 gene. A. Summary of deep sequencing of CD177 gene
(located at 43.8Mb, band q13.2, of the forward strand of chromosome 19 in human genome 19, 43.3 Mb and q13.31 for hg38). Amplicons covering the
entire coding sequence of 9 exons were sequenced. 100% coverage was obtained at indicated read depths. 24 low frequency SNPs were found in exon
adjacent non-coding regions and 17 polymorphisms were identified in CD177 coding sequences. Representative allelic frequencies of nine SNPs in exon
5 and 7 are displayed according to CD177 phenotypes. Graphs were generated from Integrative Genomics Viewer from Broad Institute referenced on
hg19.B. SNV frequency of 41 variants (called from hg19) in cohort 1. Each dashed line represents genotypes from a single individual. A schematic
CD177 gene structure is shown of variants withinCD177. C. Sanger sequencing of CD177 exon 7 in DNA isolated from neutrophils (upper panel) and
saliva (lower panel) from three individuals same as shown inA. Reference (Ref) and variant (Var) read frequencies derived from deep sequencing and
CD177 neutrophil phenotypes for each subject were indicated on the top of each panel.
doi:10.1371/journal.pgen.1006067.g002
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altered CD177 expression, 5 out 17 (35%) coding variations in CD177 are predicted to be dam-
aging with high scores of PolyPhen2, CADD and SIFT (S2 Table) [38, 39, 40]. A mutation sig-
nificance cutoff (MSC) study demonstrated that with a 99% confidence interval (CI), CD177-
specific cutoff for PolyPhen2 and CADD are 0.523 and 5.946 respectively, predicting high
impact of five PolyPhen2 predicted and three CADD predicted damaging variations [41].
CD177 g.7497A allele frequency correlates with CD177 expression
We examined CD177 g.7497A allele frequency in individuals with different CD177 phenotypes
in both cohorts. This analysis included a total of sixteen CD177null individuals. We observed a
strong correlation between expression of CD177 and CD177 g.7497A allele frequency in cohort
2 (Fig 3A). In particular, all individuals homozygous for CD177 g.7497T were CD177null. Indi-
viduals with a g.7497A allele read frequency of 50% have larger proportions of CD177hi and
fewer circulating CD177neg neutrophils than individuals with 25% A alleles (Fig 3B and 3C).
These data are consistent with the proposition that presence of the reference g.7497A allele
determines neutrophil CD177 expression, whilst the CD177 g.7497T allele specifies the abun-
dance of CD177neg neutrophils. Exclusive presence of T at g.7497 accounts for the CD177null
phenotype.
We expressed genotype-phenotype data according to all nucleotide variants identified by
deep sequencing, and by reference to CD177 surface phenotypes in cohort 1 (Fig 3D). This
makes obvious the concordance for read frequencies of each exon 7 variant. There is a correla-
tion between each haplotype encompassing exon 7 and CD177 phenotype. We found 100%
variant exon 7 reads in all CD177null individuals, 75% variant exon 7 reads in 7/9 of the
Table 1. List of 17 protein-coding variations showed their incidence, genomic location, polymorphisms and alteration in amino acids (A.A.) in
GRCh 37 (hg19) and updated version GRCh38 (hg38).
Variations Prevalence Region Position (hg19) SNV A.A. Position (hg38) SNV A.A. Position (CD177) Position (cDNA)
rs45441892 23/39 Exon 1 43,857,873 G->C A3P 43,353,721 G->C A3P g.49 c.9
s45553433 2/39 Exon 2 43,858,044 A->T H31L 43,353,892 A->T H31L g.220 c.92
rs45571738 7/39 43,858,066 G->A L38L 43,353,914 G->A L38L g.242 c.114
novel 39/39 Exon 4 43,859,815 C->G P128A 43,355,663 C->G P128A g.1991 c.381
rs12981714 38/39 43,860,192 T->G V184G 43,356,040 T->G V184G g.2368 c.551
rs12980412 38/39 Exon 5 43,860,251 G->A D204N 43,356,099 G->A D204N g.2427 c.610
rs12981771 38/39 43,860,255 T->G M205R 43,356,103 T->G M205R g.2431 c.614
rs57802244 1/39 43,864,507 T->C M237T 43,360,355 T->C M237T g.6683 c.710
rs10425835 27/39 Exon 6 43,864,548 C->A L251I 43,360,396 C->A L251I g.6724 c.751
novel 39/39 43,865,316 C->G A261G 43,361,164 G->C G261A g.7492 c.782
novel 39/39 43,865,320 C->A T262T 43,361,168 A->C T262T g.7496 c.786
novel 39/39 43,865,321 T->A X263K 43,361,169 A->T K263X g.7497 c.787
rs200145410 39/39 Exon 7 43,865,324 A->G S264G 43,361,172 G->A G264S g.7500 c.790
rs200006364 10/39 43,865,325 G->T S264I 43,361,173 G->T G264V g.7501 c.791
rs201266439 39/39 43,865,333 G->A A267T 43,361,181 A->G T267A g.7509 c.798
rs17856829 15/39 Exon 8 43,865,692 G->A A348T 43,361,540 G->A A348T g.7968 c.1022
rs78718189 4/39 Exon 9 43,866,449 G->A G431R 43,362,297 G->A G431R g.8625 c.1281
The incidence of nucleotide variation expressed as a percentage of all reads for each individual is shown in Fig 2B. Read frequencies of 0, 50 or 100%
were observed for most SNVs across the cohort, consistent with simple Mendelian inheritance. By contrast, SNVs identified in exons 4, 5, and 7, which
were identified in almost all subjects, yielded read frequencies of approximately 25, 50 or 75%, from which we inferred the existence of four alleles (two bi-
allelic loci) (Fig 2A and 2B, Table 1, S3A, S3B and S3C Fig). At least two of these loci contained the premature stop codon (g.7497A>T) in all individuals.
doi:10.1371/journal.pgen.1006067.t001
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Fig 3. CD177 g.7497A allele frequencies correlate to neutrophil CD177 expression. A—C. Association of
reference allele frequency (g.7497A) with neutrophil CD177 expression measured by geometric mean
fluorescence intensity (MFI) of CD177 on the cell surface of total neutrophils (A), percentages of CD177hi
neutrophils (B), and CD177neg neutrophils (C) in the blood of cohort 2. D. Heat map of variant allele frequency
(determined by deep sequencing) and neutrophil phenotypes (determined by flow cytometry) in cohort 1.
doi:10.1371/journal.pgen.1006067.g003
Genetic Specification of CD177
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individuals with the next lowest ratios of CD177hi to CD177neg cells, and 50% variant exon 7
reads in 26/28 individuals expressing the highest proportion of CD177hi cells.
CD177 novel variants reflect sequence divergence from CD177P1
pseudogene
According to Human Genome Assembly 106 (build 38), human chromosome 19 contains
CD177 (CD_00019.10) separated by 10kb from the CD177P1 pseudogene, which comprises
sequences homologous with CD177 exons 4–9 on the minus strand (NC_000019.10) (Fig 4A).
Analysis of these reference sequences, and alternative sequences deposited in GenBank reveals
Fig 4. CD177 andCD177P1 variations. A. CD177 locus on human chromosome 19 and a schematic comparison of CD177 and
CD177P1 genes.B. Current annotation of three copy number variations of CD177 andCD177P1 gene polymorphisms.C. CD177
reference allele frequencies of two polymorphisms, g.1991C in exon 4 and g.7497A in exon 7, of cohort 1. Each dot represents one of 40
tested subjects. 15 out of 40 subjects displayed allele frequencies of g.1991C and g.7497A simultaneously at 50%. 14/40 subjects
harboured similarly 50% g.7497A allele but 75% g.1991C. D. ProposedCD177/CD177P1 haplotypes in two loci of exon 4 (C/G) and exon
7 (A/T).CD177 gene in black line andCD177P1 in grey. The most frequent genotype is highlighted.
doi:10.1371/journal.pgen.1006067.g004
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uncertainty over the provenance of the variants we identified (Fig 4B). Comparison of human
reference CD177 gene sequences with those from other mammalian species is informative for
resolving this uncertainty (S4A, S4B and S4C Fig). The g.1991C>G variant identified in exon 4
(43,355,663, c.381C>G), which causes a proline to alanine (P128A) substitution, has not been
reported in any of the reference sequences, and is not annotated in dbSNP. The exon 5 variants
we identified as heterozygous in 39/40 subjects appear as discrepancies in reference sequences
and probably reflect differences between CD177 gene and CD177P1. Most significantly, the
exon 7 variant haplotype containing g.7497T appears to arise from CD177P1 (Fig 4B). We pos-
tulated that the CD177null phenotype arises when exon 7 reads are derived exclusively from
CD177P1, while CD177 exon7 sequence is not detected in the genome of these individuals.
The sequence homolog between CD177 and CD177P1, along with detection of two bi-alleles
of CD177 exon 4, 5 and 7 as described above, suggested that variations in these regions may
reflect sequence divergence from CD177P1. To explore this proposition further, we examined
the relation between variation g.1991C at 43,355,663 locus in exon 4 and g.7497A (43,361,169)
in exon 7 across cohort 1 (Fig 4C and 4D). We recorded read frequencies of 25, 50 and 75% for
g.1991C, but read frequencies of 0, 25 and 50% for g.7497A. Our observation of a maximum of
50% g.7497A reads is consistent with homozygosity for the T allele at the CD177P1 locus in the
population. This was also most frequently observed in 29/40 subjects, in which 15/40 subjects
were 50:50 heterozygous at both g.1991 in exon 4 and g.7497 in exon 7, suggesting homozygous
reference alleles of C/C and A/A in the two loci of CD177 gene and ‘variant’ alleles G/G and T/
T in CD177P1. Other possibilities included homozygosity at one locus but heterozygosity at the
other, or heterozygosity at both loci. Possible haplotypes are shown in Fig 4D. Analysis of hap-
lotypes between exon 4 and exon 5 showed similar results. Interestingly, linkage disequilibrium
(LD) analysis with Genome1000 data are consistent with a haplotype block encompassing
CD177P1 and only the 3’ region of CD177 (S5 Fig).
Phylogenetic analysis reveals CD177-like sequence in orang-utan and pygmy chimpanzee
(S6 Fig). However, the exonic structure of CD177 varies considerably between mammalian spe-
cies (S7 Fig), with evidence of gene duplication giving rise either to CD177-like genes (S8 Fig)
or to CD177 itself. Thus, mouse Cd177 comprises 17 exons, and with significant nucleotide
and protein sequence homology between the first and second halves of the molecule (S9 Fig).
Both halves of mouse CD177 exhibit approximately 50% amino acid homology with human
CD177 (S10 Fig).
CD177 expression is a heritable trait determined by the ratio of CD177/
CD177P1 alleles
As another approach to evaluate the association between CD177 and CD177P1 genotypes and
CD177 phenotypes, we examined CD177 expression according to the genotypes of parents and
their offspring in families where parents exhibit different ratios of A and T at CD177.g7497 (Fig
5A–5D). In pedigree 1, both parents exhibit CD177hi phenotypes, and are sequenced for CD177.
g7497A/T at 50:50 ratio according to electropherogram, from which we infer homozygous
g.7497A in CD177, since CD177P1 is homozygous T. Consistent with this, their offspring shares
the same genotype and phenotype (Fig 5A). In pedigree 2, the maternal phenotype is CD177hi
and 50:50 CD177.g7497A/T, while the paternal phenotype is CD177hi/neg, with 25:75 CD177.
g7497A/T, from which we infer A/T heterozygosity for CD177. The offspring is genotyped as
50:50 g.7497A/T (inheriting a reference CD177 allele from each parent), and exhibits a CD177hi
phenotype (Fig 5B). By contrast, pedigree 3 illustrates similar parental genotypes and pheno-
types to pedigree 2, but the offspring is 25:75 CD177.g7497A/T according to the electrophero-
gram and exhibits a CD177hi/neg phenotype, suggesting a CD177 variant allele from the father
Genetic Specification of CD177
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(Fig 5C). Finally, in pedigree 4, both parents have 25:75 g.7497A/T genotype and CD177hi/neg
phenotypes, and both offspring inherit similar phenotypes and genotypes (Fig 5D).
CD177/CD177P1 divergence confirmed by comparison of gDNA and
cDNA sequences
In order to resolve the uncertainty of CD177 reference sequence, we compared sequences of
CD177 gDNA and mRNA isolated from individuals who exhibited different CD177 phenotypes
and harboured putative CD177 polymorphisms. We sorted CD177hi and CD177neg subsets from
a subject whose 88% of neutrophils in the blood were CD177hi, amplified full-length CD177
Fig 5. An inheritable phenotype of CD177 determined by ratio of CD177/CD177P1 alleles. A-D. Pedigrees of 4 unrelated families with
different CD177 geno- and phenotypes, all exhibit Mendelian inheritance.: female,⊠: male; filled: CD177 exon 7, blank: CD177P1 exon 7.
Genotypes were also shown in schematic structures, CD177 in orange andCD177P1 in blue, with g.7497A/T polymorphisms labelled in both
alleles at CD177 andCD177P1 loci. Chromatograms showed genomic sequence trace of CD177 g.7497 labelled with ratio of Ref:Var in each
subject. Histograms showed CD177 phenotypes, numbers in corresponding colours indicating percentages of neutrophil subsets, CD177neg
in black, CD177int in orange, CD177hi in pink.
doi:10.1371/journal.pgen.1006067.g005
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cDNA from both subsets, and compared them with genomic DNA sequences determined by
deep sequencing (Fig 6A). In individuals whose neutrophils are predominantly CD177hi, CD177
transcripts are homozygous c.787A. Variant c.787T transcripts were not detected, consistent
with prediction of nonsense mediated decay (NMD) of CD177P1 transcripts.
We identified 11 CD177 polymorphisms in exons 2, 4, 5, 7 and 8, all apparently heterozy-
gous (approximately 50% of reads). Exon 2 is absent from CD177P1, therefore, we inferred that
g.242G>A is a SNP in CD177, which was confirmed by analysis of cDNA sequences (Fig 6B).
Similarly, g.7968G>A in exon 8 appears to be a CD177 SNP, whereas other putative polymor-
phisms in exons 4, 5 and 7 were not found in CD177 transcripts (Fig 6A), suggesting that they
represent divergence between CD177 and CD177P1 rather than CD177 SNPs (Fig 6B). In sum-
mary, g.1991C (exon 4), g.2368G, g.2427A and g.2431G (exon 5), and g.7492G, g.7496A,
g.7497A, g.7500G, and g.7509A (exon 7) are CD177 gene reference sequences, and variants at
these loci are actually derived from CD177P1.
Incorporation of CD177P1 exon 7 into CD177 locus causes distinctive
CD177 transcription in CD177neg neutrophils
Next, we investigated the CD177 sequences in individuals with 25:75 ratio of g.7497A/T geno-
type, which confers CD177hi/neg neutrophil phenotypes. Once again, we compared genomic
Fig 6. Analysis of CD177 variations andCD177P1 divergence from gDNA and cDNA sequence. A. CD177neg and CD177hi cells were sorted from
an individual who predominantly express CD177hi in neutrophils (left). Sequencing traces showedCD177 codon variations at indicated loci, comparing
results from gDNA deep sequencing (top), CD177 mRNA isolated from purified CD177hi cells (middle) and CD177neg neutrophils (bottom). The reference
nucleotide sequences were labelled in colour letters below. The two SNPs present in gDNA and cDNA of both cell subsets were labelled (*). B. A
schematic summary of the variations in gDNA and mRNA in neutrophils of this subject. Sequence variations were indicated on the top of the gene/
transcript and exons were indicated (E2, E4 etc) below.CD177P1 nucleotides in exon 4, 5 and 7 were outlined. CD177P1 transcripts were shown in grey
signifying expected NMDwith the stop codon variation g.7497T in red.
doi:10.1371/journal.pgen.1006067.g006
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and transcript sequences but this time from a subject with approximately equal distributions of
CD177hi and CD177neg neutrophils in peripheral blood. gDNA sequences revealed similar
abundance of variations and references bases for seven SNPs in exons 2, 4, 5 and 6. By contrast,
we observed a 25:75 ratio (reference to variant allele) for five SNPs in exon 7 (Fig 7A), consis-
tent with presence of one copy of CD177 exon 7 and three copies of CD177P1 pseudogene
derived sequence. A possible explanation is that one CD177 allele was partially replaced with
Fig 7. Ectopic and allelicCD177P1 exon 7 conversion. A. CD177hi and CD177neg neutrophils were sorted from a single donor with bimodal CD177
expression (left). Genomic variant allele frequencies were determined by deep sequencing (top), and compared with sequence variations in cDNA from
CD177hi (middle) and CD177neg neutrophils (bottom). Two CD177 transcripts were found in CD177neg neutrophils. SNPs present in gDNA and cDNA of
CD177neg subsets but absent from CD177hi cells are labelled (*). B. Schematic summaries of CD177 vs CD177P1 gDNA variations and CD177 mRNA in
two neutrophil subsets. CD177P1 derived nucleotides in exon 4, 5 and 7 are outlined, suggesting oneCD177 allele partially supplied by CD177P1 exon 7.
C&E. Genomic sequence traces in indicated loci within exon 4, 5 and 7 of two CD177null individuals. OnlyCD177P1 exon 7 sequences are detected in
CD177null subjects, who harbour bothCD177 andCD177P1 upstream elements, i.e., exon 4 (C) and exon 5 (E). D&F. Schematic genomicCD177/
CD177P1 structures of CD177null individuals as shown in C&E.G. Confirmation of ectopic and allelic CD177P1 exon 7 conversion in three subjects by
MLPA. The plots show the peak ratio of probes for indicated loci of CD177 andCD177P1 genes. Exon 2 is used as a reference read out of the CD177
gene only; probes for exon 4, 5, 7 and 9 bind to bothCD177 andCD177P1, whereas probes labelled as (P1) are specific to CD177P1 exon 5 and 7. The
graph shows one copy duplication ofCD177P1 exon 7 in blue in the same subject as shown in A & B; and two copies duplication (allelic conversion) in the
two CD177null subjects (red & orange) as shown in C-F. The subject in red also shows duplication of CD177P1 exon 5 in concordant to C & D.
doi:10.1371/journal.pgen.1006067.g007
Genetic Specification of CD177
PLOSGenetics | DOI:10.1371/journal.pgen.1006067 May 26, 2016 12 / 22
CD177P1 homolog via ectopic gene conversion, yielding a chimeric CD177 allele containing a
pre-mature stop codon (g.7497T) in exon 7 (Fig 7A and 7B).
This hypothesis was lent additional support by the presence of distinctive CD177 transcripts
in CD177neg and CD177hi cells within the same individual (Fig 7A). Monomorphic CD177
mRNA transcripts from the reference CD177 allele were recovered from CD177hi neutrophils.
By contrast, two different transcripts were recovered from CD177neg neutrophils. Besides a
same copy of CD177 reference transcript, a variant transcript was also recovered containing
eight SNPs: c.92A/T, c.114G/A, c.751C/A, c.782G/C, c.786A/C, c.787A/T, c.790G/A and
c.798A/G in CD177neg neutrophils. These SNPs corresponded exactly to genomic heterozygos-
ity of g.220A/T and g.242G/A (exons 2), g.6724C/A (exon 6) and g.7492G/C, g.7496A/C,
g.7497A/T, g.7500G/A and g.7509A/G (exon 7). Again, SNPs identified in exon 2 (g.220A>T
and g.242G>A) and exon 6 (g.6724C>A) represented common variations in CD177 gene,
whereas SNPs in exon 7 arose from CD177P1. CD177P1 derived exon 7 sequences were recov-
ered in the cDNA. This demonstrated the expression of chimeric CD177 transcripts and sup-
ported the proposition of CD177P1 exon 7 incorporation in CD177 locus (Fig 7A and 7B). This
finding proved that both intact and converted CD177 alleles are transcribed in CD177neg neu-
trophils, whereas CD177hi neutrophils express only reference allele. A mechanism of ectopic
gene conversion also explains 25:75 (ref/var) ratio of polymorphisms in exon 7 of the gene.
To confirm this structural change, we performed MLPA using probes specific to different
regions of CD177 and CD177P1 genes in relation to individuals with normal copy numbers of
both genes. This analysis confirmed the presence of an additional copy of CD177P1 exon 7 (Fig
7G, sample 1 in blue), in concordance with deep sequencing data (Fig 7A). These results indi-
cate ectopic gene conversion of CD177P1 exon 7 into the CD177 locus, resulting in 25:75 ratio
of CD177 g.7497 A/T alleles.
Allelic gene conversion of CD177P1 results in CD177null phenotype
All CD177null subjects were homozygous for CD177P1 derived exon 7 sequence, suggesting an
allelic gene conversion in the region (Figs 2A–2C, 7C–7F, S2D and S2F). Analysis of upstream
variations implied different homologous recombination events among CD177null individuals.
One subject harboured g.1991C>G polymorphism at 50:50 ratio (Fig 7C), indicating co-exis-
tence of two alleles of CD177 exon 4 (homozygous g.1991C) and two alleles of CD177P1
(homozygous G). By contrast, only CD177P1 derived sequence was found from exon 5 to exon
7 in the same individual, suggesting replacement of CD177 exon 5 to 7 by CD177P1 homolog
in both alleles, and chromosomal crossover occurred between exon 4 and 5 (Fig 7C and 7D).
Similarly, presence of both CD177 and CD177P1 sequences in exon 5 but exclusive CD177P1
sequence in exon 7 in another CD177null subject indicated homologous recombination between
exon 5 and 7 (Fig 7E and 7F). MLPA confirmed the presence of 4 copies of CD177P1 exon 7 in
both CD177null subjects, demonstrating allelic CD177 gene conversion (Fig 7G). Furthermore,
duplication of CD177P1 exon 5 in one subject (red) but not in another (orange) confirmed var-
ious homologous recombination occurred in CD177null subjects (Fig 7G).
Our data from both deep sequencing andMLPA support an allelic gene conversion by
CD177P1 exon 7 in CD177null subjects. CD177 exon 7 had been mistakenly annotated as a poly-
morphic pseudogene in GRCh37. It should be noted that current understanding for exon 5
sequence was incorrect too. Our data suggested that “reference” g.2368T, g.2427G and g.2431T
according database were actually linked with other CD177P1 elements and “variant” genotypes
of g.2368G, g.2427A and g.2431G should be annotated as CD177 sequence (Figs 6 and 7). Com-
plete CD177 sequence in alignment with CD177P1 is shown in S11 Fig Taken together, these
findings indicate that the stop codon responsible for the CD177null phenotype is derived from
Genetic Specification of CD177
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CD177P1. This chimeric CD177 gene has arisen by gene conversion. This would be consistent
with both the allelic frequencies observed for exon 7 haplotypes, with the transcriptional analy-
sis, and with gene structural analysis by MLPA. The allelic frequencies are in Hardy-Weinberg
equilibrium (= 0.9998) based on the genotype frequencies in our large cohort 2 (Fig 8A and 8B).
Discussion
We report evidence for the genetic specification of heterogeneous CD177 phenotypes by
ectopic and allelic conversion. We identified a novel polymorphism in exon 7 (g.7497A>T),
encoding a stop codon in place of a lysine codon. Based on analysis of more than 9000 nucleo-
tide reads from each individual and a large cohort over 500 subjects, we determined with a
high level of confidence that this codon is present in all individuals. Most individuals have both
lysine and stop codons detected, whereas in CD177null individuals, only the stop codon is
detected which is derived from CD177P1 exon 7 conversion.
Previous studies have identified variations in the transcript of CD177 deficient individuals
with no satisfactory explanation for the origin of the splicing error [30, 31]. Other investigators
have identified SNVs within CD177 gene in association with expression [32, 33], and although
this resulted in some progress, were ultimately inconclusive either because of the absence of
full length genomic sequence of CD177, or the absence of CD177null subjects (S1 Table). As a
result, the mechanisms that account or the CD177null phenotype have not been resolved.
Recently, Li and colleagues independently identified the same putative nonsense mutation in
CD177 gene reported here, and demonstrated that this variation account for lack of CD177
expression in transfected cells [34]. Our finding that the null allele arises by conversion from a
pseudogene with close sequence homology helps to explain why previous results have been
inconclusive. Indeed, we show that the CD177 reference sequences lodged in GenBank contain
inconsistencies, and have resulted from assembly of sequences from the gene and pseudogene.
CD177P1 comprises orthologs of exons 4–9 of CD177 gene. Previous studies have unsuc-
cessfully attempted to resolve the contributions of the CD177P1 [42, 43]. Resolution of this
uncertainty has been achieved here with deep sequencing of captured CD177 alleles. We have
identified portions of the CD177 gene that harbour variants with strict Mendelian inheritance,
Fig 8. Models forCD177 allelic arrangement and genotype-phenotype relation. A. A proposed allelic
arrangement model to account for CD177 variant read frequencies. CD177P1-derived segments are shown in blue
boxes and g.7497T in red lines.CD177 genes are in yellow and g.7497A in green. Prevalence of each arrangement
in cohort 2 is shown, together with calculated Hardy-Weinberg ratio.B. Model to account for observed CD177
genotype-phenotype relation.
doi:10.1371/journal.pgen.1006067.g008
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whereas exon 7 exhibits variant frequencies that could not be accounted for by the presence of
just two alleles.
Our findings demonstrated that CD177 is sometimes a chimeric gene resulting from incor-
poration of a gene segment derived from CD177P1 (including exon 7). We provide evidence in
this study that this chimeric gene has arisen by gene conversion. Gene conversion is a process
of homologous recombination involving unidirectional transfer of genetic material to dupli-
cated gene from its ancestor such as pseudogene [44]. A similar mechanism of gene conversion
from pseudogenes resulting in insertion of a nonsense codon has been reported in chronic
granulomatous disease, polycystic kidney disease, and B cell immune deficiency [45–47]. The
presence of the homologous sequences in CD177 and CD177P1 has resulted in misannotation
of CD177, and thwarted efforts to identify the genetic basis for the CD177null phenotype.
The explanation we propose for CD177null alleles within the population also appears to
account for phenotypic heterogeneity. We observed a marked concordance between levels of
CD177 expression and the number of CD177 exon 7 alleles. Thus, one allele (g.7497A read fre-
quency of 25%, by ectopic CD177P1 conversion) is associated with lower levels of CD177
expression than two alleles (g.7497 read frequency 50%). Allelic frequency is supported by
analysis of transcripts within neutrophils of subjects having various CD177 phenotypes.
CD177 expression not only varies across the population, but also within individuals.
CD177neg cells appear to be distinguished from CD177hi neutrophils. In individuals heterozy-
gous for CD177 exon 7, CD177neg cells harbor two CD177 transcripts containing CD177P1-
derived exon 7 sequences, whereas CD177hi cells express only CD177-exon 7 containing tran-
scripts. We have identified allelic and ectopic gene conversion as driving forces for CD177null
and CD177neg expression respectively. Additional investigations are merited to explore mecha-
nism of atypical CD177 expression (i.e., CD177int subset) within individuals, which might
include epigenetic changes and posttranscriptional regulation.
Absence of self-antigen predispose to a breakdown in immunological tolerance upon expo-
sure to self-antigen. Failure to acquire self-tolerance to neutrophil antigens places an individual
at risk of developing antibodies to these antigens, either as natural antibodies, or after immunisa-
tion. For neutrophil antigens, this is likely to occur after exposure to fetal antigens, or less likely,
after blood transfusion or allotransplantation. The consequences of passive transfer of neutro-
phil antibodies include TRALI, and neonatal immune neutropenia. Indeed, the first description
of neonatal alloimmune neutropenia arose in the offspring of CD177nul mothers [11]. Despite
the pathogenic role for anti-CD177 antibodies in TRALI and NAN, the lack of a method to
genotype CD177 has prevented CD177 deficiency from being investigated in TRALI causing
donors, TRALI patients [48], and pregnant women. For the first time, our study established a
method to genotype CD177nul individuals with risk of anti-CD177 antibody development after
pregnancies and infusions. Prospective studies will be necessary to characterise in more detail
the requirements for alloimmunisation and antibody production in CD177null individuals.
In summary, we have identified the genetic variant that accounts for the CD177null pheno-
type and heterogeneous CD177 expression. The mechanism appears to result from insertion of
a pseudogene derived sequence into the CD177 locus. Nevertheless, this event can be identified
as apparent homozygosity for g.7497 of CD177 gene. This discovery makes it possible to screen
individuals at risk of CD177 isoimmunisation.
Methods
Study subjects
Study subjects consisted of 40 patients with anti-neutrophil cytoplasmic autoantibodies
(ANCA) associated vasculitis (AAV) (cohort 1) and 535 healthy subjects (cohort 2) were
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examined for CD177 genotypes and phenotypes, in an effort to elucidate neutrophil mediated
autoimmunity. All research described was approved by the ACT Health Human Research Eth-
ics Committee, under protocols ETH.11.11.269 and ETH.1.15.15. Participating subjects pro-
vided written informed consent.
Neutrophil isolation, flow cytometry and cell sorting
Anticoagulant citrate dextrose solution-treated fresh blood was layered on Ficoll-Paque Plus
separation medium (GE Healthcare Life Science) at room temperature for 45 minutes to allow
erythrocytes to sediment. Leukocytes with minimal residue erythrocytes after sedimentation
were carefully layered on the top of 10 ml Ficoll-Paque Plus separation medium and centri-
fuged at 400g for 40 minutes without brake at room temperature. Neutrophils and peripheral
blood mononuclear cells (PBMC) were then recovered to separate tubes [49].
Leukocytes (approximately 1x106) were stained with fluorescent conjugated antibodies for
CD16 (3G8), CD66b (G10F5) from Biolegend, CD177 (MEM-166) from Abcam and CD177
(REA258) fromMiltenyl Biotec in Ca++Mg++ free HBSS. Data were acquired on a FACSCanto
II flow cytometer (BD Bioscience) and analysed using FlowJo software (TriStar). 1–2 million of
CD177neg and CD177hi subsets were sorted on a BD FACS Aria II from CD66b+ neutrophils
for sequencing and RNA analysis.
Sanger sequencing, amplifluor PCR, RT-PCR and MLPA
Genomic DNA was extracted from neutrophils and saliva using DNeasy Blood kit (Qiagen)
and Oragen-DNA OG-500 kits (DNAgenoTec) respectively. CD177 exon 5 and 7 sequence
was amplified with primers (CD177E5F: CAGCATCACTGACTCTCCC TC; CD177E5R:
ATGCCCCATGTGTCATCGTG; CD177E7F: AGCTTTCCCTCTCACCCTC AG;
CD177E7R: TCTGGGCCTCATTTCTCCACG), and examined in the Bioscience Research
Facility.
Two allele specific forward primers and a single common reverse primer were designed to
amplify across the polymorphisms at 19:43,361,164 (GRCh38) (CD177. g7492G/C).
GAAGGTGACCAAGTTCATGCTGACTCACATCAACCCTGGTGGG (CD177F-1) and
CD177F-2 (GAAGGTCGGAGTCAACGGATTGACTCACATCAACCCTGGTGGC) both
had a 5’ tail corresponding to fluorophores FAM and HEX respectively. The common reverse
primer was 86bp downstream within exon 7(CD177-R: CGAGGAGCAGAAGTGGGTAT).
Amplification cocktails were prepared with KASP Master Mix (LGC Group). Fluorescences
were measured after amplification. Allelic frequencies were discriminated using FLUOstar
OPTIMA (BMG Labtech).
Neutrophil RNAs were extracted with TRIzol reagent (Invitrogen) and reverse transcribed
into cDNA using Qiagen Reverse Transcription kit. Full length of CD177 transcript was ampli-
fied and sequenced with a pair of primers (CD177F: CTGGGGTTCATCCTCCCACT;
CD177R: TTAGCAGGAAGGGCAAACCA).
Multiplex ligation-dependent probe amplification (MLPA) were performed using the
MRC-Holland Salsa MLPA EK1 FAM reagent kit [50]. Probes were designed based on either
homology or discrepancy between CD177 and CD177P1 genes following previously described
criteria [51]. Oligonucleotides from Sigma-Aldrich are listed in Table 2. Probe mixes were pre-
pared in water with each oligonucleotide at a final concentration of 4 fmol/ul and MLPAs were
performed using 100ng gDNA. The products were separated by an ABI 3730 DNA Analyzer
(Applied Biosystems). Trace data were analyzed using GeneMarker (Softgenetics). Peak heights
were normalized to the average peak height of the control probes followed by normalization to
the average peak height of the control samples in cohort 1 whose sequences indicated to have
Genetic Specification of CD177
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one copy of CD177 and CD177P1 gene respectively per chromosome. Threshold values for
deletion were set at 0.75 and 1.25 for duplication.
Custom exon capture, deep sequencing, and data analysis
TruSeq Custom Amplicon libraries were prepared according to the manufacturer’s instruction
(Illumina). 76 pairs of primers were designed for amplicons, covering the entire coding regions
of three neutrophil antigen genes including CD177. High through-put paired-end sequencing
was performed on the Illuminia MiSeq platform for 500 cycles in the Bioscience Research Facil-
ity. Primary processed FATSO files were analysed with MiSeq reporter and a homemade pipe-
line developed by the Immunogenomics Bioinformatics team. BAM files were viewed with
integrative genomics viewer (the Broad Institute), comparing to reference human genome
hg19 and converted to GRCh38 (hg38).
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